| Makers Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506919 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE987A01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 93.97 |
Market Cap(₹Cr) : 87.92 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.53 | 0.04 | 0.03 | 0.57 | 10.19 |
| Total Income | 12.71 | 13.17 | 13.77 | 9.73 | 10.02 | 21.69 |
| Total Expenditure | 11.99 | 12.72 | 13.26 | 10.91 | 10.01 | 11.67 |
| PBIDT | 0.72 | 0.45 | 0.50 | -1.19 | 0.01 | 10.02 |
| Interest | 0.15 | 0.15 | 0.10 | 0.09 | 0.13 | 0.33 |
| PBDT | 0.57 | 0.30 | 0.40 | -1.28 | -0.12 | 9.70 |
| Depreciation | 0.71 | 0.71 | 0.70 | 0.69 | 0.73 | 0.71 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.03 | -0.10 | -0.03 | -0.57 | -0.08 | 0.95 |
| Reported Profit After Tax | -0.17 | -0.31 | -0.27 | -1.40 | -0.77 | 8.03 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.17 | -0.31 | -0.27 | -1.40 | -0.77 | 8.03 |
| EPS (Unit Curr.) | -0.29 | -0.53 | -0.46 | -2.38 | -1.31 | 13.62 |
| EPS (Adj) (Unit Curr.) | -0.29 | -0.53 | -0.46 | -2.38 | -1.31 | 13.62 |
| Calculated EPS (Unit Curr.) | -0.29 | -0.53 | -0.46 | -2.38 | -1.31 | 13.61 |
| Calculated EPS (Adj) (Unit Curr.) | -0.29 | -0.53 | -0.46 | -2.38 | -1.31 | 13.61 |
| Calculated EPS (Ann.) (Unit Curr.) | -1.17 | -2.11 | -1.84 | -9.50 | -5.23 | 54.46 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -1.17 | -2.11 | -1.84 | -9.50 | -5.23 | 54.46 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.90 | 5.90 | 5.90 | 5.90 | 5.90 | 5.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 5.67 | 3.56 | 3.64 | -12.27 | 0.11 | 87.13 |
| PBDTM(%) | 4.49 | 2.37 | 2.91 | -13.20 | -1.27 | 84.35 |
| PATM(%) | -1.34 | -2.45 | -1.97 | -14.43 | -8.15 | 69.83 |
